The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised
by the Japan Society of Hepatology, according to the methodology of evidence‐based …

BACKGROUND: Our previous results for treatment of hepatocellular carcinoma (HCC) with
proton beam therapy revealed excellent local control with low toxicity. Three protocols were …

BACKGROUND: The authors have published a series of studies evaluating the safety and
efficacy of proton beam therapy for the treatment of hepatocellular carcinoma in a variety of …

The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was
revised by the Japan Society of Hepatology, according to the methodology of evidence‐based …

In this paper, we discuss the role of particle therapy—a novel radiation therapy (RT) that has
shown rapid progress and widespread use in recent years—in multidisciplinary treatment. …

This paper presents the first version of clinical practice guidelines for intrahepatic
cholangiocarcinoma (ICC) established by the Liver Cancer Study Group of Japan. These guidelines …

Purpose: To evaluate the effectiveness of whole-pelvic hyperthermia (HT) added to standard
chemoradiotherapy (CRT) in locally advanced cervical cancer (CC), by investigating the …

PURPOSE: To evaluate the safety and efficacy of postoperative hyperfractionated concomitant
boost proton radiotherapy with nimustine hydrochloride for supratentorial glioblastoma …

Tumor hypoxia has been known to be associated with resistance to radiation and chemotherapy
(CRT). Hypoxia‐inducible factor‐1α (HIF‐1α), a transcription factor induced by hypoxic …

Background/Aim: The aim of the present study was to evaluate the outcomes of proton
beam therapy (PBT) concurrently combined with chemotherapy consisting of cisplatin and 5-…